Programmed Cell Death in Liver Fibrosis

Ruoyu Gao,1 Haiying Tang,2 Jingwei Mao1 1Department of Gastroenterology, First Affiliated Hospital of Dalian Medical University, Dalian, 116011, People’s Republic of China; 2Department of Respiratory and Critical Care Medicine, First Affiliated Hospital of Dalian Medical University, Dalian, 116011,...

Full description

Bibliographic Details
Main Authors: Gao R, Tang H, Mao J
Format: Article
Language:English
Published: Dove Medical Press 2023-09-01
Series:Journal of Inflammation Research
Subjects:
Online Access:https://www.dovepress.com/programmed-cell-death-in-liver-fibrosis-peer-reviewed-fulltext-article-JIR
_version_ 1797694053990531072
author Gao R
Tang H
Mao J
author_facet Gao R
Tang H
Mao J
author_sort Gao R
collection DOAJ
description Ruoyu Gao,1 Haiying Tang,2 Jingwei Mao1 1Department of Gastroenterology, First Affiliated Hospital of Dalian Medical University, Dalian, 116011, People’s Republic of China; 2Department of Respiratory and Critical Care Medicine, First Affiliated Hospital of Dalian Medical University, Dalian, 116011, People’s Republic of ChinaCorrespondence: Jingwei Mao, Department of Gastroenterology, First Affiliated Hospital of Dalian Medical University, 222 Zhongshan Road, Dalian, 116011, Liaoning Province, People’s Republic of China, Email maojingwei@dmu.edu.cnAbstract: Programmed cell death (PCD) is a comprehensive term that encompasses various forms of cell death, such as apoptosis, necroptosis, pyroptosis, ferroptosis, and autophagy, which play a crucial role in the pathogenesis of liver fibrosis. PCD facilitates the elimination of aberrant cells, particularly activated hepatic stellate cells (HSCs), which are the primary producers of extracellular matrix (ECM). The removal of HSCs may impede ECM synthesis, thereby mitigating liver fibrosis. As such, PCD has emerged as a promising therapeutic target for the development of novel drugs to treat liver fibrosis. Numerous studies have been conducted to investigate the underlying mechanisms of PCD in the elimination of activated HSCs and other aberrant liver cells in fibrotic liver tissue, including hepatocytes, hepatic sinusoid endothelial cells (LSECs), and Kupffer cells (KCs). The induction of PCD, the interplay between different forms of PCD, and the potential harm or benefit of PCD in liver fibrosis are topics of ongoing research. Evidences suggest that PCD is a complex process with dual effects on liver fibrosis. The purpose of this review is to summarize the most recent advances in PCD and liver fibrosis research.Keywords: liver fibrosis, necroptosis, pyroptosis, ferroptosis, autophagy, apoptosis
first_indexed 2024-03-12T02:52:25Z
format Article
id doaj.art-a321055491c54ad28d8353b9ab9ac7a4
institution Directory Open Access Journal
issn 1178-7031
language English
last_indexed 2024-03-12T02:52:25Z
publishDate 2023-09-01
publisher Dove Medical Press
record_format Article
series Journal of Inflammation Research
spelling doaj.art-a321055491c54ad28d8353b9ab9ac7a42023-09-03T19:02:41ZengDove Medical PressJournal of Inflammation Research1178-70312023-09-01Volume 163897391086348Programmed Cell Death in Liver FibrosisGao RTang HMao JRuoyu Gao,1 Haiying Tang,2 Jingwei Mao1 1Department of Gastroenterology, First Affiliated Hospital of Dalian Medical University, Dalian, 116011, People’s Republic of China; 2Department of Respiratory and Critical Care Medicine, First Affiliated Hospital of Dalian Medical University, Dalian, 116011, People’s Republic of ChinaCorrespondence: Jingwei Mao, Department of Gastroenterology, First Affiliated Hospital of Dalian Medical University, 222 Zhongshan Road, Dalian, 116011, Liaoning Province, People’s Republic of China, Email maojingwei@dmu.edu.cnAbstract: Programmed cell death (PCD) is a comprehensive term that encompasses various forms of cell death, such as apoptosis, necroptosis, pyroptosis, ferroptosis, and autophagy, which play a crucial role in the pathogenesis of liver fibrosis. PCD facilitates the elimination of aberrant cells, particularly activated hepatic stellate cells (HSCs), which are the primary producers of extracellular matrix (ECM). The removal of HSCs may impede ECM synthesis, thereby mitigating liver fibrosis. As such, PCD has emerged as a promising therapeutic target for the development of novel drugs to treat liver fibrosis. Numerous studies have been conducted to investigate the underlying mechanisms of PCD in the elimination of activated HSCs and other aberrant liver cells in fibrotic liver tissue, including hepatocytes, hepatic sinusoid endothelial cells (LSECs), and Kupffer cells (KCs). The induction of PCD, the interplay between different forms of PCD, and the potential harm or benefit of PCD in liver fibrosis are topics of ongoing research. Evidences suggest that PCD is a complex process with dual effects on liver fibrosis. The purpose of this review is to summarize the most recent advances in PCD and liver fibrosis research.Keywords: liver fibrosis, necroptosis, pyroptosis, ferroptosis, autophagy, apoptosishttps://www.dovepress.com/programmed-cell-death-in-liver-fibrosis-peer-reviewed-fulltext-article-JIRliver fibrosisnecroptosispyroptosisferroptosisautophagyapoptosis
spellingShingle Gao R
Tang H
Mao J
Programmed Cell Death in Liver Fibrosis
Journal of Inflammation Research
liver fibrosis
necroptosis
pyroptosis
ferroptosis
autophagy
apoptosis
title Programmed Cell Death in Liver Fibrosis
title_full Programmed Cell Death in Liver Fibrosis
title_fullStr Programmed Cell Death in Liver Fibrosis
title_full_unstemmed Programmed Cell Death in Liver Fibrosis
title_short Programmed Cell Death in Liver Fibrosis
title_sort programmed cell death in liver fibrosis
topic liver fibrosis
necroptosis
pyroptosis
ferroptosis
autophagy
apoptosis
url https://www.dovepress.com/programmed-cell-death-in-liver-fibrosis-peer-reviewed-fulltext-article-JIR
work_keys_str_mv AT gaor programmedcelldeathinliverfibrosis
AT tangh programmedcelldeathinliverfibrosis
AT maoj programmedcelldeathinliverfibrosis